Skip to main content
. Author manuscript; available in PMC: 2011 Feb 1.
Published in final edited form as: Biomark Med. 2010 Apr;4(2):265–280. doi: 10.2217/bmm.10.12

Figure 4. Plasma neutrophil gelatinase-associated lipocalin levels measured by Triage® neutrophil gelatinase-associated lipocalin device at various time points after cardiopulmonary bypass in subjects with no acute kidney injury (N), or with acute kidney injury (R, I or F) stratified by RIFLE criteria.

Figure 4

NGAL: Neutrophil gelatinase-associated lipocalin.

Post hoc analysis of data from reference [92].